The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Predicted occurrence, ecotoxicological risk and environmentally acquired resistance of antiviral drugs associated with COVID-19 in environmental waters
Open accessAbstract
Antiviral drugs have been used to treat the ever-growing number of coronavirus disease 2019 (COVID-19) patients. Consequently, unprecedented amounts of such drug residues discharging into ambient waters raise concerns on the potential ecotoxicological effects to aquatic lives, as well as development of antiviral drug-resistance in wildlife. Here, we estimated the occurrence, fate and ecotoxicological risk of 11 therapeutic agents suggested as drugs for COVID-19 treatment and their 13 metabolites in wastewater and environmental waters, based on drug consumption, physical-chemical property using quantitative structure-activity relationship (QSAR), and ecotoxicological and pharmacological data for the drugs. Our results suggest that the removal efficiencies at conventional wastewater treatment plants will remain low (< 20%) for half of the substances, and consequently, high drug residues (e.g. 7402 ng/L ribavirin, 4231 ng/L favipiravir, 730 ng/L lopinavir, 319 ng/L remdesivir; each combined for both unchanged forms and metabolites; and when each drug is administered to 100 patients out of 100,000 populations on a day) can be present in secondary effluents and persist in the environmental waters. Ecotoxicological risk in receiving river waters can be high (risk quotient > 1) by a use of favipiravir, lopinavir, umifenovir and ritonavir, and medium (risk quotient > 0.1) by a use of chloroquine, hydroxychloroquine, remdesivir, and ribavirin, while the risk will remain small (risk quotient < 0.1) for dexamethasone and oseltamivir. The potential of wild animals acquiring antiviral drug resistance is estimated to be small. Our prediction suggests a pressing need for proper usage and waste management of antiviral drugs as well as for improving removal efficiencies of drug residues in wastewater.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Remdesivir for the Treatment of Covid-19 — Final Report
Beigel, J. H., Tomashek, K. M., Dodd, L. E., Mehta, A. K., Zingman, B. S., Kalil, A. C., Hohmann, E., Chu, H. Y., Luetkemeyer, A., Kline, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2007764 · Cited by 7,267
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs
Jeon, S., Ko, M., Lee, J., Choi, I., Byun, S. Y., Park, S., Shum, D., & Kim, S. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00819-20 · Cited by 675
Cited by
Which Micropollutants in Water Environments Deserve More Attention Globally?
Yang, Y., Zhang, X., Jiang, J., Han, J., Li, W., Li, X., Yee Leung, K. M., Snyder, S. A., & Alvarez, P. J. J. (2022) · Environmental Science & Technology · doi:10.1021/acs.est.1c04250 · Cited by 570
Li, T., Duan, L., Du, M., Shi, L., Zhu, W., Wang, C., & Fan, J. (2024) · Microchemical Journal · doi:10.1016/j.microc.2023.109697 · Cited by 1
Metadata
- Authors
- Kuroda, K., Li, C., Dhangar, K., & Kumar, M.
- Venue
- Science of The Total Environment
- Publisher
- Elsevier BV
- Published
- 2021-07
- Volume
- 776
- Pages
- 145740
- ISSN
- 0048-9697 (ISSN-L)
- OpenAlex
- W3129871533
- Cited by
- 226
- References
- 2
- FWCI
- 8.81
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Predicted occurrence, ecotoxicological risk and environmentally acquired resistance of antiviral drugs associated with COVID-19 in environmental waters. https://app.cochat.ai/papers/10.1016/j.scitotenv.2021.145740
- The paper
- Kuroda, K., Li, C., Dhangar, K., & Kumar, M. (2021). Predicted occurrence, ecotoxicological risk and environmentally acquired resistance of antiviral drugs associated with COVID-19 in environmental waters. Science of The Total Environment. https://doi.org/10.1016/j.scitotenv.2021.145740
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.